A000250 Stock Overview
Sam Chun Dang Pharm. Co., Ltd engages in the manufacturing and sale of pharmaceutical products in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Sam Chun Dang Pharm. Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩100,200.00 |
| 52 Week High | ₩151,200.00 |
| 52 Week Low | ₩49,750.00 |
| Beta | 1.43 |
| 1 Month Change | 17.19% |
| 3 Month Change | 38.21% |
| 1 Year Change | 31.32% |
| 3 Year Change | 88.70% |
| 5 Year Change | 116.88% |
| Change since IPO | 5,936.15% |
Recent News & Updates
Optimistic Investors Push Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Up 28% But Growth Is Lacking
Mar 21
Sam Chun Dang Pharm (KOSDAQ:000250) Seems To Use Debt Quite Sensibly
Feb 26Recent updates
Optimistic Investors Push Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Up 28% But Growth Is Lacking
Mar 21Sam Chun Dang Pharm (KOSDAQ:000250) Seems To Use Debt Quite Sensibly
Feb 26Investors Who Bought Sam Chun Dang Pharm (KOSDAQ:000250) Shares Five Years Ago Are Now Up 644%
Feb 09Could The Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Ownership Structure Tell Us Something Useful?
Jan 05
Here's Why Sam Chun Dang Pharm (KOSDAQ:000250) Can Manage Its Debt Responsibly
Dec 01Shareholder Returns
| A000250 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -2.4% | -3.8% | -3.3% |
| 1Y | 31.3% | 3.6% | 1.2% |
Return vs Industry: A000250 exceeded the KR Pharmaceuticals industry which returned 3.6% over the past year.
Return vs Market: A000250 exceeded the KR Market which returned 1.2% over the past year.
Price Volatility
| A000250 volatility | |
|---|---|
| A000250 Average Weekly Movement | 15.5% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.9% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A000250's share price has been volatile over the past 3 months.
Volatility Over Time: A000250's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1943 | 394 | Dae-In Yoon | www.scd.co.kr |
Sam Chun Dang Pharm. Co., Ltd engages in the manufacturing and sale of pharmaceutical products in South Korea. It provides ethical and over the counter products in various therapeutic areas comprising ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company is also involved in exporting activities.
Sam Chun Dang Pharm. Co., Ltd Fundamentals Summary
| A000250 fundamental statistics | |
|---|---|
| Market cap | ₩2.28t |
| Earnings (TTM) | -₩10.38b |
| Revenue (TTM) | ₩192.67b |
11.8x
P/S Ratio-219.6x
P/E RatioIs A000250 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A000250 income statement (TTM) | |
|---|---|
| Revenue | ₩192.67b |
| Cost of Revenue | ₩96.06b |
| Gross Profit | ₩96.61b |
| Other Expenses | ₩106.99b |
| Earnings | -₩10.38b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -456.23 |
| Gross Margin | 50.14% |
| Net Profit Margin | -5.39% |
| Debt/Equity Ratio | 16.2% |
How did A000250 perform over the long term?
See historical performance and comparison